Similar articles

• Cholinesterase inhibitors in Alzheimer's disease: donepezil or rivastigmine?

  Sharma JC. Sharma JC. Int J Clin Pract. 2002 Jul-Aug;56(6):414-5. Int J Clin Pract. 2002. PMID: 12166537 No abstract available.
• The new cholinesterase inhibitors for Alzheimer's disease, Part 1: their similarities are different.

  Stahl SM. Stahl SM. J Clin Psychiatry. 2000 Oct;61(10):710-1. doi: 10.4088/jcp.v61n1001. J Clin Psychiatry. 2000. PMID: 11078030
• The new cholinesterase inhibitors for Alzheimer's disease, Part 2: illustrating their mechanisms of action.

  Stahl SM. Stahl SM. J Clin Psychiatry. 2000 Nov;61(11):813-4. doi: 10.4088/jcp.v61n1101. J Clin Psychiatry. 2000. PMID: 11105732 No abstract available.
• Use of cholinesterase inhibitors for treatment of Alzheimer disease.

  Hake AM. Hake AM. Cleve Clin J Med. 2001 Jul;68(7):608-9, 613-4, 616. doi: 10.3949/ccjm.68.7.608. Cleve Clin J Med. 2001. PMID: 11453078 Review.
• Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.

  Prasher VP. Prasher VP. Int J Geriatr Psychiatry. 2004 Jun;19(6):509-15. doi: 10.1002/gps.1077. Int J Geriatr Psychiatry. 2004. PMID: 15211527 Review.